---
title: "NewGenIvf Group Limited (NIVF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NIVF.US.md"
symbol: "NIVF.US"
name: "NewGenIvf Group Limited"
industry: "医疗服务"
---

# NewGenIvf Group Limited (NIVF.US)

| Item | Detail |
|------|--------|
| Industry | 医疗服务 |
| Location | 美股市场 |
| Website | [www.nivf.global](https://www.nivf.global) |

## Company Profile

NewGenIvf 集团有限公司是一家投资控股公司，提供辅助生殖服务，帮助在泰国、柬埔寨、香港和吉尔吉斯斯坦的夫妇和个人进行生育治疗。该公司的生育治疗解决方案包括体外受精（IVF）、单精子注射（ICSI）、胚胎培养、激素血液检测、传染病检测、染色体筛查、宫腔镜检查、精子分析、分选、清洗和冷冻，以及卵子冷冻。它还提供 IVF 治疗；代孕及相关护理服务，包括定期体检，以及为代孕母亲提供的维生素、补充剂和药物；以及增值服务，包括营养指导、心理咨询、针灸和翻译服务，以补充 IVF 治疗。该公司通过其诊所提供服务

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-26T04:30:12.000Z

**Overall: C (0.46)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 59 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -19.43% |  |
| Net Profit YoY | 21690.95% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.03 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 788758.54 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 4.58M |  |


**Multi Score**: C

#### Profit Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 153.04% | A |
| Profit Margin | 381.16% | A |
| Gross Margin | 9.20% | E |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -19.43% | E |
| Net Profit YoY | 21690.95% | A |
| Total Assets YoY | 2314.56% | A |
| Net Assets YoY | 506.20% | A |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 26.24% | C |
| OCF YoY | -19.43% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.25 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 19.18% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - NewGenIvf Group Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "A",
      "indicators": [
        {
          "name": "ROE",
          "value": "153.04%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "381.16%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "9.20%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-19.43%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "21690.95%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "2314.56%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "506.20%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "26.24%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-19.43%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.25",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "19.18%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | TalkSpace (US.TALK) | C | B | A | A | A | A |
| 02 | 信诺保险 (US.CI) | B | B | A | D | B | B |
| 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 04 | 实验美控 (US.LH) | B | C | B | C | B | B |
| 05 | 奎斯特诊疗 (US.DGX) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 0.05 | 1/79 | 2.77 | 0.08 | 0.05 |
| PB | 0.03 | 2/79 | 0.18 | 0.05 | 0.03 |
| PS (TTM) | 0.17 | 6/79 | 0.41 | 0.29 | 0.18 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-06T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.80 |
| Highest Target | 225.00 |
| Lowest Target | 225.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/NIVF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NIVF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NIVF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.